Results filed 3 November 2026 · Market cap ₹1,74,990 crore · PE 77.3
GrowthGuidance raisedTranscript read
Revenue
+69.0%
on a year ago
EBITDA
+81.9%
on a year ago
Profit to shareholders
+78.9%
on a year ago
EBITDA margin
28.6%
+0.9 pts on last quarter
Solar Industries reported a 69% YoY surge in Q2 FY27 consolidated net sales to INR 3,519 crore, with PAT rising 80% YoY to INR 650 crore on strong execution across all divisions. The order book stood at INR 20,178 crore, heavily tilted toward defense (INR 17,568 crore), supported by imminent closure of a ~INR 3,000 crore Guided Pinaka order. Management reiterated high confidence in exceeding its annual revenue guidance of INR 14,000 crore and achieving average EBITDA margins above 29% for FY27.
Solar Industries India Limited, Q2 FY27₹ crore, consolidated
Q2 FY27
Q1 FY27
vs previous quarter
Q2 FY26
vs a year ago
Revenue
3,519
3,668
−4.1%
2,082
+69.0%
Operating profit (EBIT)
918
935
−1.9%
492
+86.5%
Operating margin
26.1%
25.5%
+58 bps
23.6%
+245 bps
Other income
15.37
8.52
+80.4%
29.18
−47.3%
Exceptional items
0
0
–
−0.94
–
Profit before exceptional items and tax
878
903
−2.8%
490
+79.0%
Profit to shareholders
617
653
−5.4%
345
+78.9%
Share of joint ventures' and associates' profit
−0.35
8.75
n.m.
0
n.m.
Earnings per share (₹)
68.19
72.11
−5.4%
38.12
+78.9%
Source: Solar Industries India Limited’s filing to NSE, 3 November 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.
What stood out
Massive 69% YoY consolidated revenue growth driven by broad-based performance and defense doubling YoYSourceConsolidated revenue was INR 3,519 crores for the quarter, up 69% YoY; Defence revenue rose 98% YoY to INR 1,002 crores (Presentation page 4, 5; Press Release page 2).
Order book stands at INR 20,178 crore, with defense comprising 87% of the total bookSourceOrder book status: CIL & SCCL INR 2,610 Cr, Defence INR 17,568 Cr, total INR 20,178 Cr (Presentation page 8; Manish Nuwal, Transcript original page 10).
Near-term closure of INR ~3,000 crore Guided Pinaka rocket order, bringing cumulative Pinaka family orders to INR 9,000 croreSourceGuided Pinaka order size should be around INR 3,000 crores, concluding very soon, bringing total Pinaka variants to around INR 9,000 crores (Manish Nuwal, Transcript original page 6).
Guidance
Metric
Guidance
Period
Consolidated RevenueSourceManish Nuwal, Transcript original page 4, 9
Expected to cross / surpass stated guidance of INR 14,000 crores
FY27
Defense RevenueSourceManish Nuwal, Transcript original page 9
Expected to cross INR 4,500 crores (already achieved ~INR 1,935 cr in H1)
FY27
EBITDA MarginSourceManish Nuwal, Transcript original page 9
Expected to average above 29% for the full year (higher than initial ~28% target)
FY27
Domestic Explosives Volume GrowthSourceManish Nuwal, Transcript original page 11
Targeting 10% to 15% volume growth annually vs 6% to 7% industry growth
Annual / FY28 onwards
Management stated it expects to comfortably surpass initial FY27 guidance of INR 14,000 crore revenue, INR 4,500 crore defense revenue, and ~28% EBITDA margin, supported by H1 performance and order pipeline.
Tailwinds
Triple-digit / high double-digit growth across defense and commercial explosivesSourceQ2 YoY customer basket revenue: Domestic Explosives up 61% to INR 963 cr, International Explosives up 57% to INR 1,515 cr, and Defence up 98% to INR 1,002 cr (Presentation page 5).
Favorable domestic mining weather during seasonal monsoon periodSourceDemand was supported by lower or below average monsoon in most mining markets, resulting in better domestic sales (Manish Nuwal, Transcript original page 5).
Operational leverage boosting operating marginsSourceConsolidated EBITDA margin expanded 107 bps YoY to 29.02% in Q2 FY27 from 27.95% in Q2 FY26 (Presentation page 4; Press Release page 2).
Headwinds
Sharp increase in finance costsSourceInterest and finance costs jumped 77% YoY to INR 55 crores in Q2 FY27 from INR 31 crores in Q2 FY26 (Presentation page 4).
Increase in net indebtednessSourceNet debt increased by 35.8% to INR 1,177 crores as of HYFY27 compared to INR 867 crores at FY26 end (Presentation page 9).
Macro and supply chain volatilitySourceManagement cited geopolitical issues, supply chain disruptions, and fluctuating commodity prices as headwinds preventing a formal mid-year guidance increase (Manish Nuwal, Transcript original page 9).
New businesses and products
new product · Final stage of price negotiation
Guided Pinaka Rockets Order
Expected benefit
Addition of ~INR 3,000 crores to order book, taking total Pinaka family orders to ~INR 9,000 crores
Risks
Contract finalization and signing delays typical of defense procurement
Timeline
Expected to conclude before end of FY27
SourceManish Nuwal, Transcript original page 6, 10
new product · Concluding internal trials; field trials scheduled
Bhargavastra Loitering / Defense System
Expected benefit
Huge domestic and international commercial order pipeline once trials complete
Risks
Long defense cycle conversion from trials to commercial order placement
Timeline
Internal and field trials to conclude within calendar year 2026
SourceManish Nuwal, Transcript original page 6, 7
capacity expansion · Manufacturing facility set up; deliveries of intermediate product commenced
155 mm Artillery Shells and Intermediate Products
Expected benefit
Scale addressable market globally and capture export orders
Risks
Gestation periods and product qualification timelines
Timeline
Final product expected to be ready by end of FY27
SourceManish Nuwal and Kavish Parekh, Transcript original page 6, 12
acquisition · Awaiting regulatory and other approvals
Omnia Acquisition
Expected benefit
Scaling international explosives operations and geographic expansion
Risks
Integration risk and inclusion of non-core agri business
Timeline
Pending receipt of approvals
SourceManish Nuwal, Transcript original page 7, 11
new business · Participated in development programs; trials underway
Tactical Missile Development Programs
Expected benefit
Expansion from rockets into full missile integration following government opening of tech to private sector
Risks
Lengthy RFP and procurement timelines (1 to 1.5 years post trials)
Timeline
Orders expected in 2+ years
SourceManish Nuwal, Transcript original page 7, 11
Things to check
Revenue up over 60%: check for an acquisition or a weak year-ago quarter
Significant increase in net debt alongside high capital expenditure and finance costsSourceNet debt rose 35.8% to INR 1,177 crores in H1 FY27 from INR 867 crores at FY26 end; Q2 interest cost surged 77% YoY to INR 55 crores (Presentation page 4, 9).
Reluctance to provide transparency on acquisition details and defense program executionSourceManagement declined to provide information on the acquisition of Omnia's agri business and explicitly shut down product-level operational questions on 155 mm shells (Transcript original page 7, 12).
How the call went
Management was confident on overall momentum and order book scale, but repeatedly deflected specific queries on 155mm ammunition, UAVs, Omnia transaction details, and multi-year outlook.
Specific or vague
Provided clear contract size quantification for Pinaka variants (~INR 3,000 cr new, INR 9,000 cr total) and total order book breakups, but withheld segment breakups for future years and refused SKU-level numbers.
Candour
Mixed. Management was realistic about multi-year conversion cycles in defense and missiles, but was defensive and evasive regarding M&A and product-specific inquiries.
The hard questions
Hard questions on the strategic value/margin impact of Omnia's agri business and timelines for 155 mm artillery shells were brushed aside without answers.
What analysts pressed on
Volume growth runway in domestic commercial explosives once ammonium nitrate raw material price increases normalize in FY28.
Execution and conversion timelines on defense programs including Bhargavastra, 155 mm shells, and MALE UAVs.
Closing timeline and business mix impact of the Omnia acquisition, specifically regarding its agriculture business.
Answers that sidestepped
Refused to answer questions on Omnia's agricultural business accretion, saying 'there is no more updates to be provided at this stage... questions can be answered once the acquisition is completed' (Manish Nuwal, Transcript original page 7).
Deflected questions on 155 mm delivery status and timelines, answering: 'More clarity on each product is not possible from my side. So you have to stay with the total order book' (Manish Nuwal, Transcript original page 12).
Declined to give forward guidance or domestic/export split for FY28/FY29 defense business, stating the call was strictly limited to quarterly and half-yearly results (Manish Nuwal, Transcript original page 8).
Deflected technical questions regarding technology and AI integration by telling the analyst to visit the factory in Nagpur instead of asking on a concall (Manish Nuwal, Transcript original page 9).
Numbers against the story
Management emphasized strong organic momentum and 'super performance from domestic market', attributing it to below-average monsoons. However, while domestic explosives revenue grew 61% YoY, it fell 29% sequentially from INR 1,361 crores in Q1 FY27 to INR 963 crores in Q2 FY27. Furthermore, while reported top-line and operating profit grew ~70-75% YoY, finance costs jumped 77% YoY and net debt increased to INR 1,177 crores from INR 867 crores at FY26 end.
Figures: the company’s results filing with NSE, linked under the table.
Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.